CTLA4 and gastric cancer: In addition, it has been shown that tumor-infiltrating FoxP3highCD45RA− effector Tregs, which express PD-1, are highly activated, express high levels of CTLA-4 and are associated with hyper progressive disease in patients with advanced gastric cancer (52).